MACRAE SANDY (PRESIDENT, CEO AND DIRECTOR) reported 2 transactions at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2026ACC: 0001675687-26-000004
DirectorOfficer· PRESIDENT, CEO AND DIRECTOR
Since Feb 2026
-38.93K
Net shares
Net seller
$18.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
38.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.29K
Price / share
$0.47
Trade value
$2.50K
% of position
0.3%
2/24/2026
1.95M→1.94M
Common Stock
Direct
Shares
−33.64K
Price / share
$0.47
Trade value
$15.81K
% of position
1.7%
2/25/2026
1.94M→1.91M
Total
Net shares
−38.93K
Net value
-$18.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −5.29K | $0.47 | $2.50K | 0.3% | 1.95M | 1.94M |
| Common Stock Direct | 2/25/2026 | F · Tax Withholding | −33.64K | $0.47 | $15.81K | 1.7% | 1.94M | 1.91M |
| Total | −38.93K | -$18.31K | ||||||
Derivative Transactions0
No derivative transactions reported